What must a med spa in Delaware report to the board?
Facility · part of The Practice Perimeter
Short answer
Three things, within 30 days: any partial or full loss of hospital privileges for adverse events, unprofessional conduct or competency; any medical society discipline; and any substantiated violence, threat, abuse or neglect — the facility owes this duty too.
Delaware names three things and a 30-day deadline, and the duty is on the facility as well as the physician. Every certificate holder and health care facility “has a duty to report to the Board within 30 days: a. Any partial or full removal of hospital privileges based on adverse events, unprofessional conduct or competency issues; and b. Any disciplinary action taken by a medical society against that person; and c. Any reasonably substantiated incidents involving violence, threat of violence, abuse, or neglect by a person toward any other person.”
24 Del. C. § 1730(b)(1) · verified Sep 8, 2026 · regulatory monitoring, not legal advice
Related Delaware rules
Delaware is one of the states that says office use out loud, which makes its answer on compounded semaglutide different from most. Nothing in this title is meant to limit a prescriber’s ability under pre-existing law to order a compounded medication for use in the prescriber’s practice, as permitted by State of Delaware and federal law. A prescriber may order compounded product for use in the practice rather than against a named patient — but only so far as other Delaware and federal law already allow, so this preserves an existing ability and creates none.
24 Del. C. § 2502(7) (Delaware EXPRESSLY preserves office-use ordering by a prescriber) · verified Sep 6, 2026
The definition itself is the familiar pair. “Compounding” means the preparation, assembling, packaging, or labeling of a drug as the result of a practitioner’s prescription or initiative based on the relationship of the practitioner or patient with the pharmacist in the course of professional practice or for the purpose of, or incident to, research, teaching, or chemical analysis and not for sale or dispensing.
24 Del. C. § 2502(7) (definition of “Compounding” — the two limbs) · verified Sep 6, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- New Jersey
- New Mexico
- Ohio
- Pennsylvania
- Texas
- West Virginia
Related Delaware questions
- Does a med spa have to register or hold a license in Delaware?
- What are the license fees to open a med spa in Delaware?
Get Delaware changes as they publish
We scan the Delaware legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Delaware rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).